IP Library Assignment 061561/0842
Patent Assignment
Reel/Frame 061561/0842

Change of Name

Recorded: 2022-09-28 Pages: 2
Assignor
CELL THERAPEUTICS, INC.
Executed: 2014-06-04
Assignee
CTI BIOPHARMA CORP.
3101 WESTERN AVE., SUITE 800, SEATTLE, WASHINGTON, 98121
Covered Property (1)
Oxygen Linked Pyrimidine Derivatives
Application: 16/677,080 →
Publication: US 2020/0071339
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 28, 2022
From: BLANCHARD, STEPHANIE; LEE, CHENG HSIA ANGELINE; NAGARAJ, HARISH KUMAR MYSORE; POULSEN, ANDERS
To: S*BIO PTE LTD.
Reel/Frame 061244/0723 →
Assignment of Assignor's Interest Sep 28, 2022
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 061244/0838 →
Merger Oct 3, 2024
From: CTI BIOPHARMA CORP.
To: SOBI, INC.
Reel/Frame 068782/0512 →